SAYOKO HACKLER: Open Payments
NPI 1902270457 · WAIANAE, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,177 in 99 payments from 14 companies in 2025. Trend: 2023 $2,046 · 2024 $3,074 · 2025 $2,177
Food & beverage: $2,177
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $609 |
| Lilly USA, LLC | 18 | $397 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $193 |
| Xeris Pharmaceuticals, Inc. | 11 | $180 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $144 |
| Insulet Corporation | 7 | $141 |
| Mannkind Corporation | 5 | $130 |
| Dexcom, Inc. | 1 | $98 |
| Corcept Therapeutics | 2 | $83 |
| Tandem Diabetes Care, Inc. | 2 | $57 |
Products named: MOUNJARO, JARDIANCE, Kerendia, RECORLEV, Omnipod, AFREZZA, Wegovy, Dexcom G6 Transmitter.
Industry payments across HI — which companies pay providers there.
